Please assess the completion status of the following clinical trial:

Trial Title: Impact of C-arm CT in Patients With HCC Undergoing TACE: Optimal Imaging Guidance

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Patients must be affected by HCC~Patients must be 18 years old or older~Patients must have received an abdominal CT, PET/CT scan or MRI, completed prior to the TACE procedure.~Ability to understand and the willingness to sign a written informed consent document.~Exclusion Criteria:~Subjects under the age of 18~Pregnant women

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- C-arm CT + DSA as needed' (Type: EXPERIMENTAL): In the group of subjects randomized in this group, the image guidance component of the procedure will be conducted by the acquisition of 3D CT-like images during a trans-hepatic arterial injection of iodinated contrast agent for road mapping the tumor feeding vessels and supplemented by DSA as needed by the operating physician as imaging guidance for planning tumor(s) treatment approach.
- DSA only (Type: ACTIVE_COMPARATOR): In the group of subjects randomized in this group, present standard of care, i.e DSA imaging only will be used by the operating physician to map out the tumor vessels and used for treatment approach. Additional 3D CT-like images will be obtained, but only used if the operator cannot perform adequate planning using DSA alone.

Based on this trial design, predict the completion outcome and termination type (if applicable).